Concepedia

Isabel Burghardt

IB

Statistics

Publications

15

Citations

579

H-Index

13

Active since

2007

Affiliations

University Hospital of Zurich(Current)

University of Zurich

Heidelberg University

University of Tübingen

Isabel Burghardt is an author at University Hospital of Zurich specializing in oncology, medicine, and molecular oncology.

Publications per year

2007–2021

15

Publications

15

Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363

Michael Weller, Patrick Roth, Felix Sahm et al. · JNCI Journal of the National Cancer Institute · 2017 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +12

Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition

Shanmugarajan Krishnan, Emese Szabó, Isabel Burghardt et al. · Oncotarget · 2015 · 66 citations · Full text

Medicine, Neurosurgery, Oncology +16

Pirfenidone inhibits TGF-β expression in malignant glioma cells

Isabel Burghardt, Felix Tritschler, Christiane A. Opitz et al. · Biochemical and Biophysical Research Communications · 2007 · 65 citations

Medicine, Oncology, Pharmacology +12

Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma

Katharina Seystahl, Alexandros Papachristodoulou, Isabel Burghardt et al. · Molecular Cancer Therapeutics · 2017 · 60 citations

Medicine, Cancer Biology, Oncology +14

The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway

Manuela Silginer, Isabel Burghardt, Dorothee Gramatzki et al. · Oncogene · 2015 · 59 citations

Life Sciences, Cell Biology, Molecular Biology +14

1–5 of 15